Drugs that treat type‑2 diabetes and obesity, like Ozempic and Wegovy, may also help the mind. They belong to a group called GL‑1 receptor agonists. A new, very large study found that people who took these medicines visited the psychiatrist less often and missed fewer work days because of mental‑health problems.
People with obesity or diabetes often feel sad, worried, or stressed. At the same time, those with mental‑health issues are more likely to gain weight or develop diabetes. Scientists wanted to see if medicines for the body could also lift the mood.
Study Followed Almost 100,000 People
Researchers used Swedish health registers from 2009 to 2022. Almost 100,000 people were tracked, and more than 20,000 of them used GL‑1 drugs at some point. The data let the team compare times when a person was on the drug with times when they were not.
Big Drops in Depression, Anxiety, and Hospital Visits
When people took the drug semaglutide (the main ingredient in Ozempic and Wegovy), their need for psychiatric hospital care fell by 42 %. They also took fewer sick‑days. The chance of being diagnosed with depression was 44 % lower, and anxiety went down by 38 %.
Lower Risk of Substance Problems and Suicidal Thoughts
Hospital care and missed work because of substance use dropped by 47 % while on semaglutide. The medicines were also linked to a smaller risk of suicidal behavior.
Why Might the Drugs Help the Brain?
The exact reason is still a mystery. It could be because people lose weight, feel better about their bodies, drink less alcohol, or have steadier blood‑sugar levels. Some scientists think the drugs might also act directly on the brain’s reward system.
Published in a Top Psychiatry Journal
The results appeared in The Lancet Psychiatry. Earlier, smaller studies gave mixed answers. This huge, long‑term analysis gives stronger proof that GL‑1 medicines do more than control blood sugar and weight—they may also lift mental health.